Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: B cell Lineage Envelope Design from RV144 Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2015-10-20 |
| Study Made Public: | 2017-11-22 |
Title
Investigating monoclonal antibody neutralization breadth and potency after delayed and repetitive boosting with ALVAC-HIV and AIDSVAX B/E
Description
CAVD 527 is a monoclonal antibody screening study evaluating broadly neutralizing antibodies in RV144 and RV305 subjects.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.